Abstract 4142349: Multidisciplinary Approach to Definitive Management of Chylopericardium with Percutaneous Thoracic Duct Embolization

Background: Conservative management of chylopericardium with pericardiocentesis, TPN, and octreotide has a high rate of recurrence. On the other hand, surgical management is invasive and can also result in treatment failure as well. Percutaneous approach has rarely been studied in this population. Case: A 26-year-old female was admitted for recurrent idiopathic chylopericardium after failing management with pericardiocentesis. On presentation, echocardiogram demonstrated a 5.4 cm pericardial effusion without hemodynamic compromise. Fluid studies showed turbid white fluid with a triglyceride level of 1,622 mg/dL. A pericardial window was performed, and patient was started on octreotide with fat-free diet. However, high chylous output continued for one week. After multidisciplinary discussion with cardiology, thoracic surgery, radiology, and interventional radiology, a nuclear medicine lymphangiogram was completed. This demonstrated a focal area of intense tracer activity at the level of pulmonary trunk. Subsequent lymphangiogram showed dilated lymphatic channels with reflux and stasis in this area. The thoracic duct was successfully embolized. Chylous output significantly decreased, and patient was discharged. An echo at one month follow-up showed complete resolution of pericardial effusion. Discussion: Although the clinical presentation was consistent with chylopericardium, management was complicated after patient failed treatment with several approaches. At this stage, invasive surgery to ligate the thoracic duct versus continued drainage in the outpatient setting was being considered. A collaborative approach guided the right imaging modality and therapeutic intervention to definitively manage chylopericardium efficiently without significant morbidity. Furthermore, it suggested that percutaneous thoracic duct embolization may be a viable treatment option for recurrent idiopathic chylopericardium refractory to conventional management. Conclusion: A multidisciplinary approach with nuclear medicine testing and percutaneous intervention can be an effective approach to certain cases of idiopathic chylopericardium.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4142349
Citations
1
Primary Topic
Lymphatic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4142349: Multidisciplinary Approach to Definitive Management of Chylopericardium with Percutaneous Thoracic Duct Embolization

Jayini Thakker, Laith Derbas, Steve Attanasio, Jeffrey S. Soble et al.
1 citations
Circulation
Lymphatic Disorders and Treatments
0.57
article

Abstract 4142349: Multidisciplinary Approach to Definitive Management of Chylopericardium with Percutaneous Thoracic Duct Embolization

Jayini Thakker, Laith Derbas, Steve Attanasio, Jeffrey S. Soble, Nelish Ardeshna, Natasha Rana, Bülent Arslan, Neeraj Jolly
article en
1 citations

Abstract

Background: Conservative management of chylopericardium with pericardiocentesis, TPN, and octreotide has a high rate of recurrence. On the other hand, surgical management is invasive and can also result in treatment failure as well. Percutaneous approach has rarely been studied in this population. Case: A 26-year-old female was admitted for recurrent idiopathic chylopericardium after failing management with pericardiocentesis. On presentation, echocardiogram demonstrated a 5.4 cm pericardial effusion without hemodynamic compromise. Fluid studies showed turbid white fluid with a triglyceride level of 1,622 mg/dL. A pericardial window was performed, and patient was started on octreotide with fat-free diet. However, high chylous output continued for one week. After multidisciplinary discussion with cardiology, thoracic surgery, radiology, and interventional radiology, a nuclear medicine lymphangiogram was completed. This demonstrated a focal area of intense tracer activity at the level of pulmonary trunk. Subsequent lymphangiogram showed dilated lymphatic channels with reflux and stasis in this area. The thoracic duct was successfully embolized. Chylous output significantly decreased, and patient was discharged. An echo at one month follow-up showed complete resolution of pericardial effusion. Discussion: Although the clinical presentation was consistent with chylopericardium, management was complicated after patient failed treatment with several approaches. At this stage, invasive surgery to ligate the thoracic duct versus continued drainage in the outpatient setting was being considered. A collaborative approach guided the right imaging modality and therapeutic intervention to definitively manage chylopericardium efficiently without significant morbidity. Furthermore, it suggested that percutaneous thoracic duct embolization may be a viable treatment option for recurrent idiopathic chylopericardium refractory to conventional management. Conclusion: A multidisciplinary approach with nuclear medicine testing and percutaneous intervention can be an effective approach to certain cases of idiopathic chylopericardium.

CirculationVol. 150(Suppl_1)
Rush University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 28%
Lymphatic Disorders and Treatments
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.